Remove 2020 Remove BioTech Remove Patient Experience Remove Telemedicine
article thumbnail

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

Health Populi

in May and June 2020. Top-line, Accenture points to four pillars on which the pharma industry can “reinvent its relevance,” as the report title suggests: To express greater empathy, understanding the patient experience of delaying treatment, financial impacts, and mental health challenges the pandemic has caused.

article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Evolution and Benefits of DHTs in Neurology Trials DHTs – like wearables, mobile health apps, and telemedicine platforms – have for example significantly impacted the design and execution of neurology trials. in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025.